Clinical trial
Pilot Trial of Pravastatin as a Novel Prophylactic Medicine to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
NCT05524246 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Trial of Pravastatin as a Novel Prophylactic Medicine to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 27, 2023
- Completion date
- March 5, 2025
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endothelial injury, hematopoietic stem cell transplant (hsct)